On April 25, 2026, Kyodai Collaborative supported a lecture by the Kyoto University Center for Cancer Immunotherapy and Immunobiology (CCII) in New York City. The lecture explored the current situation and future directions of the Nobel Prize-winning immunotherapy in cancer treatment, pioneered by Dr. Tasuku Honjo.
The webinar participants listened to a video message from Dr. Tasuku Honjo and two presentations by scholars from Japan and the U.S. Dr. Kenji Chamoto from CCII discussed the discovery of cancer immunotherapy, current research, and the outlook for the future, followed by Dr. Hans-Guido Wendel’s lecture on the current state of cancer research in a U.S.-based laboratory and the potential for new cancer treatments. The audience attentively listened to a heartfelt video message and letters from patients who recovered from cancer through immunotherapy. The event concluded with a Q&A session with numerous insightful questions.
At the venue, invited guests, including U.S.-based Japanese professionals, American donors, and Kyoto University alumni, built networks to advance cancer immunotherapy together.
The webinar recording is now available. https://youtu.be/10gNZ9SfXps
Please explore the real impact of cancer immunotherapy, which has saved thousands of lives, and join the effort to advance scientific research aimed at controlling nearly all types of cancer by 2050.
How to support CCII, the first research hub in Japan that exclusively focuses on cancer immunotherapy. Visit the website.
It was a pleasure for Kyodai Collaborative to support the event, the CCII’s new initiative to raise funds in the U.S. We will continue to commit to our mission of promoting Kyoto University’s cutting-edge research through accelerated collaboration with Kyoto University.
